FDA Upgrades Recall of 732,000 Bottles of Blood Pressure Medication

A recall notice says that lots of carvedilol, a beta blocker, have elevated levels of a type of carcinogenic substance.

Sign outside of the Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. Andrew Kelly/Reuters

More than 700,000 bottles of the blood pressure drug carvedilol have been recalled across the United States due to the presence of a carcinogenic substance, with the Food and Drug Administration (FDA) upgrading the recall to Class II.

The FDA said a total of 732,960 bottles of carvedilol tablets in various dosages are under recall, according to an updated list of enforcement reports issued on June 4. The recall was initiated in February, but the FDA upgraded its classification last week.